EyePoint Pharmaceuticals, Inc.

Q3 2026 13F Holders

Symbol
EYPT
CUSIP
30233G209
Type
Equity
Class
COM NEW
Num filers
193
Total reported value, excl. options
$301M
Manager Report Date Value ($000) Shares